Rhenman & Partners Asset Management Ab Upped By $310,000 Its Abbvie (ABBV) Stake; Mid-con Energy Partners LP Has 1.44 Sentiment

May 30, 2017 - By Adrian Mccoy

Rhenman & Partners Asset Management Ab increased Abbvie Inc (ABBV) stake by 4.55% reported in 2016Q4 SEC filing. Rhenman & Partners Asset Management Ab acquired 5,000 shares as Abbvie Inc (ABBV)’s stock rose 6.17%. The Rhenman & Partners Asset Management Ab holds 115,000 shares with $7.20 million value, up from 110,000 last quarter. Abbvie Inc now has $104.73 billion valuation. The stock decreased 0.39% or $0.26 on May 26, reaching $66.06. About shares traded. AbbVie Inc (NYSE:ABBV) has risen 10.63% since May 30, 2016 and is uptrending. It has underperformed by 6.07% the S&P500.

Mid-Con Energy Partners, LP is engaged in the ownership, acquisition, exploitation and development of producing oil and natural gas properties in North America, with a focus on enhanced oil recovery . The company has market cap of $62.61 million. The Company’s properties are located in the Mid-Continent and Permian Basin regions of the United States in over five areas: Southern Oklahoma; Northeastern Oklahoma; parts of Oklahoma, Colorado and Texas within the Hugoton; Texas Gulf Coast, and Texas within the Eastern Shelf of the Permian. It currently has negative earnings. The Firm operates approximately 100% of its properties, as calculated on a barrel of oil equivalent (Boe) basis, through its affiliate, Mid-Con Energy Operating, LLC (Mid-Con Energy Operating).

The stock increased 1.49% or $0.03 on May 26, reaching $2.05. About shares traded. Mid-Con Energy Partners LP (MCEP) has declined 26.46% since May 30, 2016 and is downtrending. It has underperformed by 43.16% the S&P500.

Analysts await Mid-Con Energy Partners LP (NASDAQ:MCEP) to report earnings on August, 7.

Rr Advisors Llc holds 0.21% of its portfolio in Mid-Con Energy Partners LP for 610,000 shares. Oppenheimer & Co Inc owns 394,464 shares or 0.03% of their US portfolio. Moreover, Bank Of America Corp De has 0% invested in the company for 2,300 shares. The United Kingdom-based Barclays Plc has invested 0% in the stock. Capital Advisors Inc Ok, a Oklahoma-based fund reported 13,269 shares.

Investors sentiment decreased to 0.98 in 2016 Q4. Its down 0.05, from 1.03 in 2016Q3. It is negative, as 86 investors sold ABBV shares while 555 reduced holdings. 99 funds opened positions while 531 raised stakes. 1.03 billion shares or 0.70% less from 1.04 billion shares in 2016Q3 were reported. 49,204 are held by 1832 Asset Mngmt L P. Connecticut-based Webster National Bank N A has invested 0.1% in AbbVie Inc (NYSE:ABBV). Alps Advsr accumulated 626,301 shares or 0.29% of the stock. 22,000 were reported by West Family Invs. Alley Ltd Liability Com owns 43,086 shares or 1.19% of their US portfolio. Tcw Gp invested in 155,491 shares. Capital Advisors Inc Ok holds 0.13% or 30,553 shares in its portfolio. Roundview Ltd Liability Company reported 34,576 shares stake. Shoker Inv Counsel Incorporated holds 1.35% of its portfolio in AbbVie Inc (NYSE:ABBV) for 25,984 shares. Schroder Mngmt accumulated 0.39% or 3.28 million shares. Fisher Asset Limited Liability Company has invested 0.08% in AbbVie Inc (NYSE:ABBV). Pennsylvania-based Cim Invest Mangement has invested 0.42% in AbbVie Inc (NYSE:ABBV). Granite Invest Advsrs owns 4,317 shares. Moreover, Private Advisor Gru Ltd Llc has 0.28% invested in AbbVie Inc (NYSE:ABBV). Raab Moskowitz Asset Management Ltd Limited Liability Company has invested 0.37% in AbbVie Inc (NYSE:ABBV).

Since December 2, 2016, it had 0 insider buys, and 9 insider sales for $19.62 million activity. On Friday, March 10 the insider RICHMOND TIMOTHY J. sold $1.47M. $2.61M worth of AbbVie Inc (NYSE:ABBV) shares were sold by Schumacher Laura J. $390,654 worth of stock was sold by CHASE WILLIAM J on Friday, December 2. $2.88M worth of AbbVie Inc (NYSE:ABBV) was sold by ALBAN CARLOS on Thursday, May 4. HURWICH THOMAS A. sold $143,031 worth of AbbVie Inc (NYSE:ABBV) on Tuesday, February 28. $4.63 million worth of AbbVie Inc (NYSE:ABBV) was sold by GONZALEZ RICHARD A on Wednesday, March 8. 5,132 shares were sold by Michael Robert A., worth $335,068.

Rhenman & Partners Asset Management Ab decreased Jazz Pharmaceuticals Plc (NASDAQ:JAZZ) stake by 9,080 shares to 50,920 valued at $5.55 million in 2016Q4. It also reduced Merck & Co Inc (NYSE:MRK) stake by 130,000 shares and now owns 70,000 shares. Halozyme Therapeutics Inc (NASDAQ:HALO) was reduced too.

Among 18 analysts covering Abbvie Inc (NYSE:ABBV), 7 have Buy rating, 1 Sell and 10 Hold. Therefore 39% are positive. Abbvie Inc had 36 analyst reports since July 21, 2015 according to SRatingsIntel. The firm has “Market Perform” rating given on Monday, June 6 by Cowen & Co. As per Tuesday, October 18, the company rating was initiated by Leerink Swann. The firm earned “Equal-Weight” rating on Tuesday, December 1 by Barclays Capital. Jefferies maintained AbbVie Inc (NYSE:ABBV) on Monday, May 29 with “Buy” rating. Jefferies upgraded the stock to “Buy” rating in Monday, December 7 report. On Monday, November 2 the stock rating was upgraded by Morgan Stanley to “Overweight”. Goldman Sachs maintained the stock with “Buy” rating in Friday, March 10 report. JP Morgan downgraded AbbVie Inc (NYSE:ABBV) on Thursday, September 8 to “Neutral” rating. As per Monday, March 7, the company rating was downgraded by Goldman Sachs. Raymond James initiated the shares of ABBV in report on Friday, September 2 with “Outperform” rating.